BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22192858)

  • 1. The inorganic perspectives of neurotrophins and Alzheimer's disease.
    Travaglia A; Pietropaolo A; La Mendola D; Nicoletti VG; Rizzarelli E
    J Inorg Biochem; 2012 Jun; 111():130-7. PubMed ID: 22192858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper, BDNF and Its N-terminal domain: inorganic features and biological perspectives.
    Travaglia A; La Mendola D; Magrì A; Nicoletti VG; Pietropaolo A; Rizzarelli E
    Chemistry; 2012 Dec; 18(49):15618-31. PubMed ID: 23135810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of neurotrophins with the p75NTR common neurotrophin receptor: a comprehensive molecular modeling study.
    Shamovsky IL; Ross GM; Riopelle RJ; Weaver DF
    Protein Sci; 1999 Nov; 8(11):2223-33. PubMed ID: 10595525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc Interactions With Brain-Derived Neurotrophic Factor and Related Peptide Fragments.
    Travaglia A; La Mendola D
    Vitam Horm; 2017; 104():29-56. PubMed ID: 28215299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophins: from pathophysiology to treatment in Alzheimer's disease.
    Schulte-Herbrüggen O; Jockers-Scherübl MC; Hellweg R
    Curr Alzheimer Res; 2008 Feb; 5(1):38-44. PubMed ID: 18288930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-region of neurotrophins determines the processing efficiency.
    Nomoto H; Takaiwa M; Mouri A; Furukawa S
    Biochem Biophys Res Commun; 2007 May; 356(4):919-24. PubMed ID: 17395157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
    Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
    J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophin small-molecule mimetics.
    Xie Y; Longo FM
    Prog Brain Res; 2000; 128():333-47. PubMed ID: 11105692
    [No Abstract]   [Full Text] [Related]  

  • 11. The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor.
    Travaglia A; Arena G; Fattorusso R; Isernia C; La Mendola D; Malgieri G; Nicoletti VG; Rizzarelli E
    Chemistry; 2011 Mar; 17(13):3726-38. PubMed ID: 21394800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of neurotrophins and their receptors in cultured human keratinocytes.
    Marconi A; Terracina M; Fila C; Franchi J; Bonté F; Romagnoli G; Maurelli R; Failla CM; Dumas M; Pincelli C
    J Invest Dermatol; 2003 Dec; 121(6):1515-21. PubMed ID: 14675204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins.
    Mendoza E; Miranda-Barrientos JA; Vázquez-Roque RA; Morales-Herrera E; Ruelas A; De la Rosa G; Flores G; Hernández-Echeagaray E
    Neuroscience; 2014 Nov; 280():156-70. PubMed ID: 25241069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer's disease.
    Angelucci F; Gelfo F; Fiore M; Croce N; Mathé AA; Bernardini S; Caltagirone C
    Can J Physiol Pharmacol; 2014 Aug; 92(8):621-30. PubMed ID: 25026432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutants of metal binding site M1 in APP E2 show metal specific differences in binding of heparin but not of sorLA.
    Dienemann C; Coburger I; Mehmedbasic A; Andersen OM; Than ME
    Biochemistry; 2015 Apr; 54(15):2490-9. PubMed ID: 25835329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.
    Faller P
    Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide.
    Faller P; Hureau C; Berthoumieu O
    Inorg Chem; 2013 Nov; 52(21):12193-206. PubMed ID: 23607830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of the neurotrophins and their receptors.
    Allen SJ; Dawbarn D
    Clin Sci (Lond); 2006 Feb; 110(2):175-91. PubMed ID: 16411894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.